| 05/08 | PROTAGONIST THERAPEUTICS : Quarterly Report for Quarter Ending June 30, 2022 (Form 10-Q) |  |
| 05/08 | PROTAGONIST THERAPEUTICS : Q2 Earnings Snapshot | |
| 04/08 | PROTAGONIST THERAPEUTICS, INC MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDIT.. | |
| 04/08 | Protagonist Therapeutics, Inc. Reports Earnings Results for the Second Quarter and Six .. | |
| 04/08 | PROTAGONIST THERAPEUTICS : Reports Second Quarter 2022 Financial Results and Provides Corp.. | |
| 19/07 | Protagonist Therapeutics Reports Granting of Inducement Award | |
| 24/06 | PROTAGONIST THERAPEUTICS, INC.(NASDA : PTGX) added to Russell 3000 Value Index | |
| 24/06 | PROTAGONIST THERAPEUTICS, INC.(NASDA : PTGX) dropped from Russell 2000 Growth Index | |
| 24/06 | PROTAGONIST THERAPEUTICS, INC.(NASDA : PTGX) added to Russell 2000 Value Index | |
| 24/06 | PROTAGONIST THERAPEUTICS, INC.(NASDA : PTGX) dropped from Russell Small Cap Comp Growth In.. | |
| 24/06 | PROTAGONIST THERAPEUTICS, INC.(NASDA : PTGX) dropped from Russell 3000 Growth Index | |
| 24/06 | PROTAGONIST THERAPEUTICS, INC.(NASDA : PTGX) added to Russell 2500 Value Index | |
| 24/06 | PROTAGONIST THERAPEUTICS, INC.(NASDA : PTGX) added to Russell 3000E Value Index | |
| 24/06 | PROTAGONIST THERAPEUTICS, INC.(NASDA : PTGX) dropped from Russell 3000E Growth Index | |
| 24/06 | PROTAGONIST THERAPEUTICS, INC.(NASDA : PTGX) dropped from Russell Microcap Growth Index | |
| 24/06 | PROTAGONIST THERAPEUTICS, INC.(NASDA : PTGX) added to Russell Small Cap Comp Value Index | |
| 24/06 | PROTAGONIST THERAPEUTICS, INC.(NASDA : PTGX) dropped from Russell 2500 Growth Index | |
| 24/06 | PROTAGONIST THERAPEUTICS, INC.(NASDA : PTGX) added to Russell Microcap Value Index | |
| 02/06 | PROTAGONIST THERAPEUTICS, INC : Submission of Matters to a Vote of Security Holders (form .. | |
| 01/06 | Protagonist Therapeutics to Participate at the Jefferies Healthcare Conference | |
| 26/05 | Protagonist Therapeutics, Inc. to Present Updated Phase 2 Rusfertide Clinical Results i.. | |
| 05/05 | PROTAGONIST THERAPEUTICS, INC MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDIT.. | |
| 04/05 | PROTAGONIST THERAPEUTICS : Q1 Earnings Snapshot | |
| 04/05 | Protagonist Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended Mar.. | |
| 26/04 | Protagonist Therapeutics' Shares Plummet After Reporting Trial Data for Inflammatory Bo.. | |
| 26/04 | Top Midday Decliners | |
| 26/04 | Top Premarket Decliners | |
| 26/04 | PROTAGONIST THERAPEUTICS : Announces Topline Data from Phase 2 IDEAL Study of PN-943 in Ul.. | |
| 26/04 | PROTAGONIST THERAPEUTICS, INC : Financial Statements and Exhibits (form 8-K) | |
| 26/04 | TRANSCRIPT : Protagonist Therapeutics, Inc. - Special Call | |
| 25/04 | Protagonist Therapeutics Announces Topline Data from Phase 2 IDEAL Study of PN-943 in U.. | |
| 25/04 | Protagonist Therapeutics Announces Topline Data from Phase 2 IDEAL Study of PN-943 in U.. | |
| 20/04 | PROTAGONIST THERAPEUTICS : Initial Statement of Beneficial Ownership (Form 3) | |
| 19/04 | Protagonist Therapeutics Reports Granting of Inducement Awards | |
| 14/04 | SECTOR UPDATE : Health Care Stocks Fading Late, Stop Just Shy of Higher Close | |
| 14/04 | Top Midday Decliners | |
| 14/04 | Protagonist Stock Tumbles Thursday as FDA Plans to Rescind Rusfertide Breakthrough Desi.. | |
| 14/04 | SECTOR UPDATE : Health Care Stocks Edging Lower on Thursday | |
| 14/04 | SECTOR UPDATE : Health Care | |
| 14/04 | Wall Street Treads Water Pre-Bell; Jobless Claims Rise | |
| 14/04 | SECTOR UPDATE : Health Care Stocks Lean Lower Premarket Thursday | |
| 14/04 | SECTOR UPDATE : Health Care | |
| 14/04 | Top Premarket Decliners | |
| 14/04 | Protagonist Therapeutics Gets FDA Letter to Rescind Breakthrough Therapy Designation fo.. | |
| 14/04 | Protagonist Shares Tumble After FDA Says It May Pull Rusfertide Breakthrough Designatio.. | |
| 13/04 | Protagonist Therapeutics Gets FDA Letter to Rescind Breakthrough Therapy Designation fo.. | |
| 13/04 | PROTAGONIST THERAPEUTICS, INC : Other Events, Financial Statements and Exhibits (form 8-K) | |
| 13/04 | Protagonist Therapeutics, Inc. Expects to Announce Top-Line Data from Its Phase 2 Clini.. | |
| 31/03 | PROTAGONIST THERAPEUTICS, INC : Change in Directors or Principal Officers (form 8-K) | |
| 28/03 | Protagonist Therapeutics Names Asif Ali Finance Chief | |
| 28/03 | Protagonist Therapeutics Announces Appointment of Asif Ali as Executive Vice President .. | |
| 28/03 | Protagonist Therapeutics Announces Appointment of Asif Ali as Executive Vice President .. | |
| 23/03 | PROTAGONIST THERAPEUTICS, INC : Change in Directors or Principal Officers (form 8-K) | |
| 23/03 | Protagonist Therapeutics, Inc. Announces Resignation of Don Kalkofen as Principal Finan.. | |
| 23/03 | Protagonist Therapeutics, Inc. Announces Resignation of Don Kalkofen, Chief Financial O.. | |
| 16/03 | Protagonist Therapeutics Gets $25 Million Milestone Payment from J&J's Janssen Biotech | |
| 16/03 | Protagonist Therapeutics Earns $25 Million Milestone Payment from Janssen Biotech for D.. | |
| 01/03 | PROTAGONIST THERAPEUTICS, INC Management's Discussion and Analysis of Financial Condit.. | |
| 01/03 | PROTAGONIST THERAPEUTICS : Reports Fourth Quarter and Full Year 2021 Financial Results and.. | |
| 28/02 | PROTAGONIST THERAPEUTICS : Q4 Earnings Snapshot | |
| 28/02 | Protagonist Therapeutics, Inc. Reports Earnings Results for the Full Year Ended Decembe.. | |
| 28/02 | Protagonist Therapeutics, Inc. Reports Earnings Results for the Fourth Quarter Ended De.. | |
| 28/02 | Protagonist Therapeutics, Inc. Announces Pivotal Phase 3 VERIFY Study of Rusfertide in .. | |
| 22/02 | PROTAGONIST THERAPEUTICS, INC : Change in Directors or Principal Officers (form 8-K) | |
| 10/02 | Protagonist Therapeutics to Present at the 11th Annual SVB Leerink Global Healthcare Co.. | |
| 11/01 | TRANSCRIPT : Protagonist Therapeutics, Inc. Presents at JPMorgan 40th Annual Healthcare Co.. | |
| 04/01 | /C O R R E C T I O N -- Protagonist Therapeutics, Inc./ | |
| 2021 | INSIDER SELL : Protagonist Therapeutics | |
| 2021 | Protagonist Therapeutics Presents Updated Phase 2 Rusfertide Data | |
| 2021 | Protagonist Therapeutics to Present at the JMP Securities Hematology and Oncology Summi.. | |
| 2021 | Protagonist Therapeutics Picks PN-235 for Mid-Stage Trials in Multiple Indications | |
| 2021 | Protagonist Therapeutics Announces the Selection of Oral Peptide PN-235 into Phase 2 Cl.. | |
| 2021 | Protagonist Therapeutics Announces Selection of Oral Peptide PN-235 into Phase 2 Clinic.. | |
| 2021 | Protagonist Therapeutics Announces Positive Phase 2a Data Supporting the Potential Use .. | |
| 2021 | Protagonist Therapeutics Announces 'Positive Data' for Rusfertide as Possible Hereditar.. | |
English (USA)
English (UK)
English (Canada)
Deutsch (Deutschland)
Deutsch (Schweiz)
Español
Français (France)
Italiano
Nederlands (Nederland)
Rapport
